<SEC-DOCUMENT>0001088875-24-000098.txt : 20241009
<SEC-HEADER>0001088875-24-000098.hdr.sgml : 20241009
<ACCEPTANCE-DATETIME>20241009102031
ACCESSION NUMBER:		0001088875-24-000098
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20241009

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AbCellera Biologics Inc.
		CENTRAL INDEX KEY:			0001703057
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91923
		FILM NUMBER:		241361735

	BUSINESS ADDRESS:	
		STREET 1:		2215 YUKON STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V5Y 0A1
		BUSINESS PHONE:		(604) 559-9005

	MAIL ADDRESS:	
		STREET 1:		2215 YUKON STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V5Y 0A1

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BAILLIE GIFFORD & CO
		CENTRAL INDEX KEY:			0001088875
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		CALTON SQUARE
		STREET 2:		1 GREENSIDE ROW
		CITY:			EDINBURGH
		STATE:			X0
		ZIP:			EH13AN
		BUSINESS PHONE:		00441312752000

	MAIL ADDRESS:	
		STREET 1:		CALTON SQUARE
		STREET 2:		1 GREENSIDE ROW
		CITY:			EDINBURGH
		STATE:			X0
		ZIP:			EH13AN
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001088875-23-000005</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001088875</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>2</amendmentNo>
      <securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>09/30/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001703057</issuerCik>
        <issuerName>AbCellera Biologics Inc.</issuerName>
        <issuerCusip>00288U106</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>2215 YUKON STREET</com:street1>
          <com:street2>2215 YUKON STREET</com:street2>
          <com:city>VANCOUVER</com:city>
          <com:stateOrCountry>A1</com:stateOrCountry>
          <com:zipCode>V5Y 0A1</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>BAILLIE GIFFORD &amp; CO</reportingPersonName>
      <citizenshipOrOrganization>X0</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>9677624.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>12894703.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>12894703.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>4.4</classPercent>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>AbCellera Biologics Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>2215 YUKON STREET, 2215 YUKON STREET, VANCOUVER, BRITISH COLUMBIA, CANADA, V5Y 0A1.</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Baillie Gifford &amp; Co</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>Calton Square
1 Greenside Row
Edinburgh
EH1 3AN
Scotland
UK</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Scotland UK</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>FI</typeOfPersonFiling>
        <otherTypeOfPersonFiling>Investment adviser</otherTypeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>12,894,703</amountBeneficiallyOwned>
        <classPercent>4.38%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>9,677,624</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>12,894,703</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ? 240.14a-11.

By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to investment advisers is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>BAILLIE GIFFORD &amp; CO</reportingPersonName>
      <signatureDetails>
        <signature>Grant Meikle</signature>
        <title>Threshold &amp; Transaction Reporting Manager</title>
        <date>10/09/2024</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
